Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets
Revolution Medicines, Inc. Deferred Tax Assets and Other Non-Current Assets decreased by 2.0% to $14.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $13.13M to $14.48M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 117.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2024
How to read this metric
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Peer comparison
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
Metric ID:
deferred_tax_assets_other_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $264.00K | $264.00K | $758.00K | $851.00K | $725.00K | $856.00K | $2.86M | $2.77M | $2.69M | $11.35M | $7.03M | $4.16M | $8.27M | $10.28M | $1.74M | $13.13M | $31.42M | $14.87M | $14.78M | $14.48M |
| QoQ Change | — | +0.0% | +187.1% | +12.3% | -14.8% | +18.1% | +233.8% | -3.0% | -2.9% | +321.9% | -38.1% | -40.9% | +98.9% | +24.2% | -83.0% | +653.8% | +139.3% | -52.7% | -0.6% | -2.0% |
| YoY Change | — | — | — | — | +174.6% | +224.2% | +276.9% | +225.7% | +271.2% | >999% | +146.1% | +50.0% | +207.5% | -9.5% | -75.2% | +215.7% | +279.7% | +44.7% | +748.4% | +10.3% |
Range$264.00K – $31.42M
CAGR+132.3%
Avg YoY Growth+251.0%
Median YoY Growth+211.6%
Current Streak3 quarters decline
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s deferred tax assets and other non-current assets?
- Revolution Medicines, Inc. (RVMD) reported deferred tax assets and other non-current assets of $14.48M in Q1 2026.
- How has Revolution Medicines, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Revolution Medicines, Inc.'s deferred tax assets and other non-current assets increased by 10.3% year-over-year, from $13.13M to $14.48M.
- What is the long-term trend for Revolution Medicines, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s deferred tax assets and other non-current assets has grown at a 117.3% compound annual growth rate (CAGR), from $305.00K to $14.78M.
- What does deferred tax assets and other non-current assets mean?
- The total value of long-term tax assets and other miscellaneous long-term assets.